Grupo Amigas do Peito contra o Câncer de Mama - Bauru/SP - Informações sobre o tratamento e combate ao Câncer de Mama.

Referências Bibliográficas

Veja aqui uma lista com os principais livros e publicações sobre o assunto câncer de mama e sexualidade feminina:

1- Instituto Nacional do Câncer; Ministério da Saúde. Câncer no Brasil: dados dos registros de câncer de base populacional, vol 3. Rio de Janeiro (Brasil): INCA; 2003; [ citado em 25 de outubro de 2005]. Disponível em: http// www. Inca.gov.Br/regpop/2003.

2- Pöhls UG, Renner SP, Fasching PA, Lux MP, Kreis H, Ackermann S, et al. Awareness of breast cancer incidence and risk factors among healthy women. Eur J of Can Prev. 2004;13 (4): 249-56.

3- Simon MS, Korczak JF, Yee CL, Malone KE, Ursin G, Bernisten L, et al. Breast cancer risk estimates for relatives of white and african american women with breast cancer in the women’s contraceptive and reproductive experiences study. J Clinl Oncol. 2006; 24(16): 2498-504,.

4- Nunes FLS. Esquema de diagnóstico auxiliado por computador para detecção de agrupamentos de microcalcificações por processamento de imagens mamográficas [dissertação]. São Carlos (SP): USP. Curso de Engenharia de São Carlos; 1997.

5- Pecorelli S, Favalli G, Zigliani L, Odicino F. Cancer in woman. Int J Gynecol and Obst. 2003; 82(3): 369-79.

6- Wunsch FV,  Moncau JE. Cancer mortality in Brazil 1980-1995: regional patters and trends. Rev Assoc Med Bras.2002;  48 (3): 250-7.

7- Benshushan A, Brzezinski A. hormonal manipulations and breast cancer. Obstet Gynaecol Surv. 2002; 57 (5): 314-23.

8- Robert SA, Strombom I, Trentham-Dietz A, Hampton JM, McElroy JA, Newcomb PA, et al. Socieconomic risk factors for breast cancer distinguishing individual-and community-level effects. Epidemiology. 2004; 15 (4): 442-50.

9- Euhus DM. Breast cancer prevention in the 21st century: Defining the challenge. Breast J. 2006; 12 (2): 97-8

10- Ursin G, Longnecker MP, Haile RW, Greenland S. A meta-analysesof body mass index and risk of premonopausal breast cancer. Epidemiology.1995; 6: 137-41.

11- Longnecker MP. Alcoholic beverage consumpition in relation to risk of breast cancer. Cancer Causes Control. 1994; 5: 73-82.

12- Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, et al.  Breast cancer risk associated with proliferative breast disease end atipical hyperplasia. Cancer. 1993; 71: 1258-65.

13- Tessaro S. Epidemiologia do câncer de mama. In: Boff RA. Mastologia aplicada: abordagem multidisciplinar. 1a edição. Caxias do Sul: EDUCS; 2001. p.15-28.

14- Mant D, Vessey MP. Epidemiologia e prevenção do cancer de mama. In: Bland KI, Copeland EM. A mama: tratamento compreensivo das doenças benignas e malígnas.1a edição. São Paulo: Manole, 1994. p 265-78.  

15- Bilimoria MM, Morow M. The woman at increased risk for breast câncer: evulition and management strategies. CA  Cancer J Clin. 1995; 45: 263-78.

16- Willett WC, Rockhill B, Hankinson SE, Hunter BJ, Colditz GA. Epidemiologia e causas não genéticas do câncer de mama. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Doenças da mama. 2a edição. Belo Horizonte (MG): Medsi, 2002. p.205-59.

17- Key TJ, VerKasalo PK, Banks E. Epidemiology of breast câncer. Lancet Oncol. 2001; 2 (3): 133-40.

18- Vogel VG, Taioli E. Have we found the ultimate risk factor for breast cancer?. J Clinl Oncol. 2006; 24 (12): 1791-4.

19- Trichhopoulos D, MacMahon B, Cole P. Menopause and breast cancer risk. J Natl cancer Inst. 1972; 48: 605-13.

20- Colditz GA, Hankinson SE, Hunter DJ, Willet WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl J Med. 1995; 332: 1589-93.

21- Gertig DM, Fletcher AS, English DR, Macinnis RJ, Hopper JL, Giles GG. Hormone terapy and breast cancer: what factors modify the association?. Menopause. 2006; 13 (2): 178-84.

22- Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. New Engl J Med. 1985; 312: 146-51.

23- Greene MH. Genetics of breast cancer. Mayo Clin Proc. 1997; 72 (1): 54-65.

24- Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and Beyond. . Nature Reviews Cancer. 2004; 4 (9): 665-76.

25- Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutatin carries  Breast cancer Linkage Consortium. Lancet. 1994; 343: 692-95

26-  Wooster R, Weber BL. Breast and ovarian cancer. New Engl J Med. 2003; 348 (23): 2339-47.

27- Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R, et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. New Engl J Med. 1997; 336: 1416-21.

28- Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavpigian SV, et al. A single BRCA2 mutation in male and female breast cancer familes from Iceland with varied cancer. Nat Genet.1996; 13: 117-19.